Exencial Wealth Advisors LLC Invests $8.62 Million in The Cooper Companies, Inc. (NASDAQ:COO)

Key Points

• Exencial Wealth Advisors LLC acquired 102,187 shares of The Cooper Companies, valued at approximately $8.62 million, increasing its stake to 0.05% of the company.
• The Cooper Companies reported $1 billion in quarterly revenue, exceeding expectations, with an earnings per share (EPS) of $0.96, beating the consensus estimate by $0.03.
• Analysts have mixed ratings for the company's stock, with a consensus rating of "Moderate Buy" and an average target price of $96.73 per share.

Exencial Wealth Advisors LLC bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm bought 102,187 shares of the medical device company's stock, valued at approximately $8,619,000. Exencial Wealth Advisors LLC owned about 0.05% of Cooper Companies as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. City Holding Co. bought a new position in Cooper Companies in the first quarter worth about $34,000. Covestor Ltd raised its position in shares of Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after purchasing an additional 120 shares during the period. Larson Financial Group LLC lifted its holdings in shares of Cooper Companies by 1,071.0% in the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock worth $61,000 after purchasing an additional 664 shares during the last quarter. HM Payson & Co. lifted its holdings in shares of Cooper Companies by 147.4% in the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock worth $75,000 after purchasing an additional 532 shares during the last quarter. Finally, UMB Bank n.a. boosted its position in Cooper Companies by 16.7% during the 1st quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock valued at $76,000 after purchasing an additional 129 shares during the period. Institutional investors and hedge funds own 24.39% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on COO shares. Wall Street Zen lowered Cooper Companies from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. Needham & Company LLC upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 price target for the company in a research report on Tuesday, June 17th. BNP Paribas Exane upgraded shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price objective on the stock in a research report on Tuesday, July 22nd. Mizuho reduced their target price on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a research note on Wednesday, July 16th. Finally, Wells Fargo & Company dropped their price target on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating on the stock in a research note on Friday, May 30th. Three analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Cooper Companies has an average rating of "Moderate Buy" and a consensus target price of $96.73.

Cooper Companies Price Performance

Shares of NASDAQ:COO traded up $1.09 during trading on Friday, reaching $70.29. The company had a trading volume of 954,675 shares, compared to its average volume of 2,040,357. The firm's fifty day moving average is $71.53 and its 200 day moving average is $79.95. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10. The firm has a market capitalization of $14.06 billion, a PE ratio of 34.12, a price-to-earnings-growth ratio of 1.69 and a beta of 1.00. The Cooper Companies, Inc. has a twelve month low of $65.00 and a twelve month high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.93 by $0.03. The firm had revenue of $1 billion for the quarter, compared to analysts' expectations of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The firm's quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.85 earnings per share. On average, equities analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.